Zhang W, Huang X
Biomark Res. 2025; 13(1):43.
PMID: 40075527
PMC: 11905658.
DOI: 10.1186/s40364-025-00750-w.
Leung M, Swanton C, McGranahan N
Nat Rev Genet. 2025; .
PMID: 40065153
DOI: 10.1038/s41576-025-00825-2.
Shitara K, Janjigian Y, Ajani J, Moehler M, Yao J, Wang X
Nat Med. 2025; .
PMID: 40055521
DOI: 10.1038/s41591-025-03575-0.
Ibarra-Arellano M, Caprio L, Hada A, Stotzem N, Cai L, Shah S
Commun Biol. 2025; 8(1):361.
PMID: 40038430
PMC: 11880189.
DOI: 10.1038/s42003-025-07796-4.
Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J
MedComm (2020). 2025; 6(3):e70119.
PMID: 40027151
PMC: 11868442.
DOI: 10.1002/mco2.70119.
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids.
Papaccio F, Cabeza-Segura M, Garcia-Mico B, Gimeno-Valiente F, Zuniga-Trejos S, Gambardella V
J Exp Clin Cancer Res. 2025; 44(1):77.
PMID: 40022181
PMC: 11869439.
DOI: 10.1186/s13046-025-03308-8.
Distinct gene signatures define the epithelial cell features of mucinous appendiceal neoplasms and pseudomyxoma metastases.
Ayala C, Sathe A, Bai X, Grimes S, Shen J, Poultsides G
Front Genet. 2025; 16:1536982.
PMID: 40018643
PMC: 11865047.
DOI: 10.3389/fgene.2025.1536982.
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases.
Tagore S, Caprio L, Amin A, Bestak K, Luthria K, DSouza E
Nat Med. 2025; .
PMID: 40016452
DOI: 10.1038/s41591-025-03530-z.
IFNλ1 is a STING-dependent mediator of DNA damage and induces immune activation in lung cancer.
Godsk S, Jensen C, Larsen T, Ahrenfeldt J, Gammelgaard K, Jakobsen M
Front Immunol. 2025; 15:1525083.
PMID: 40012911
PMC: 11862833.
DOI: 10.3389/fimmu.2024.1525083.
SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10.
Tong W, Xie X, Shu Z, Nie J, Yang X, Yang F
J Transl Med. 2025; 23(1):220.
PMID: 39985078
PMC: 11846344.
DOI: 10.1186/s12967-025-06248-1.
Pharmacogenomics-based subtype decoded implications for risk stratification and immunotherapy in pancreatic adenocarcinoma.
Zhou X, Ba Y, Xu N, Xu H, Zhang Y, Liu L
Mol Med. 2025; 31(1):62.
PMID: 39972282
PMC: 11837470.
DOI: 10.1186/s10020-024-01049-6.
Breast cancer: pathogenesis and treatments.
Xiong X, Zheng L, Ding Y, Chen Y, Cai Y, Wang L
Signal Transduct Target Ther. 2025; 10(1):49.
PMID: 39966355
PMC: 11836418.
DOI: 10.1038/s41392-024-02108-4.
Bidirectional regulation of the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma.
Nie A, Xiao Z, Deng J, Li N, Hao L, Li S
World J Gastrointest Oncol. 2025; 17(2):98556.
PMID: 39958554
PMC: 11755995.
DOI: 10.4251/wjgo.v17.i2.98556.
Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.
Yang S, Seo J, Choi J, Kim S, Kuk Y, Park K
Mol Cancer. 2025; 24(1):47.
PMID: 39953555
PMC: 11829473.
DOI: 10.1186/s12943-025-02250-9.
JNK Inhibition Overcomes Resistance of Metastatic Tetraploid Cancer Cells to Irradiation-Induced Apoptosis.
Jemaa M, Setti Boubaker N, Kerkeni N, M Huber S
Int J Mol Sci. 2025; 26(3).
PMID: 39940976
PMC: 11818936.
DOI: 10.3390/ijms26031209.
Advances in Vaccine-Based Therapies for Pancreatic Cancer.
McMillan M, Soares K
J Gastrointest Cancer. 2025; 56(1):62.
PMID: 39939414
PMC: 11821674.
DOI: 10.1007/s12029-025-01165-4.
Deep visual proteomics reveals DNA replication stress as a hallmark of signet ring cell carcinoma.
Kabatnik S, Zheng X, Pappas G, Steigerwald S, Padula M, Mann M
NPJ Precis Oncol. 2025; 9(1):37.
PMID: 39910169
PMC: 11799539.
DOI: 10.1038/s41698-025-00819-7.
Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications.
Marletta S, Marcolini L, Calio A, Pedron S, Antonini P, Martelli F
Virchows Arch. 2025; .
PMID: 39899047
DOI: 10.1007/s00428-025-04041-5.
Mapping cell-cell fusion at single-cell resolution.
Gardner A, Zheng L, Howland K, Saunders A, Ramirez A, Parker P
bioRxiv. 2025; .
PMID: 39896473
PMC: 11785005.
DOI: 10.1101/2024.12.11.627873.
Loss of increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration.
Kannen V, Rasmussen M, Das S, Giuliana P, Izzati F, Choksi H
Front Immunol. 2025; 15:1513595.
PMID: 39867896
PMC: 11759301.
DOI: 10.3389/fimmu.2024.1513595.